Open AccessThe Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy
Author(s) -
Erkan Topkan,
Uğur Selek,
Berrin Pehlivan,
Ahmet Küçük,
Veysel Haksöyler,
Nulifer Kılıc Durankus,
Duygu Sezen,
Yasemin Bölükbaşı
Publication year - 2021
Publication title -
journal of inflammation research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.656
H-Index - 33
ISSN - 1178-7031
DOI - 10.2147/jir.s329611
Subject(s) - medicine , gastroenterology , receiver operating characteristic , chemoradiotherapy , cancer , pancreatic cancer , adenocarcinoma , pancreas , retrospective cohort study , cohort , oncology , nuclear medicine
We evaluated the prognostic quality of the novel pancreas cancer prognostic index (PCPI), a combination of CA 19-9 and systemic inflammation response index (SIRI), on the outcomes of locally advanced pancreas adenocarcinoma (LAPAC) patients who received concurrent chemoradiotherapy (C-CRT).